Today: 21 May 2026
Browse Category

NASDAQ:CRWD 11 February 2026 - 8 May 2026

CrowdStrike Holdings Stock Jumps 8% as AI Cybersecurity Rally Meets CEO Share Sale

CrowdStrike Holdings Stock Jumps 8% as AI Cybersecurity Rally Meets CEO Share Sale

CrowdStrike shares rose 8% Thursday as investors returned to cybersecurity stocks linked to AI demand, despite a weaker S&P 500. CEO George Kurtz sold 5,000 shares under a pre-set plan but retains over 2.2 million shares. The company will report fiscal Q1 2027 results on June 3. CrowdStrike also promoted Amanda Adams to senior vice president of global alliances.
8 May 2026
···
CrowdStrike Stock Just Cleared $500 as Cramer, Mizuho Bets Put AI Security Back in Focus

CrowdStrike Stock Just Cleared $500 as Cramer, Mizuho Bets Put AI Security Back in Focus

CrowdStrike shares surged to $503.51 Thursday morning, up $35.44, after launching a new mobile partner app and naming key partner award winners at its Americas Partner Symposium. The stock rebounded from a Wednesday drop, following an upgrade from Mizuho and renewed investor focus on its AI-security strategy. Fourth-quarter revenue rose 23% to $1.31 billion, with annual recurring revenue at $5.25 billion as of Jan. 31.
7 May 2026
········
CrowdStrike Stock Rises After Wolfe Upgrade as Anthropic AI Fears Turn Into Cybersecurity Spending Bet

CrowdStrike Stock Rises After Wolfe Upgrade as Anthropic AI Fears Turn Into Cybersecurity Spending Bet

CrowdStrike shares rose about 3% premarket Monday after Wolfe Research upgraded the stock to Outperform, citing expected higher security spending tied to Anthropic’s upcoming AI model. Wolfe set a $450 price target and said the new AI could trigger a “machine speed cyberwar.” CrowdStrike reported $5.25 billion in annual recurring revenue earlier this month. Friday’s AI-driven selloff hit other cybersecurity stocks, including Palo Alto Networks and Zscaler.
30 March 2026
····
CrowdStrike Stock Back in Focus as Cybersecurity Spending Holds Up, AI Debate Shifts

CrowdStrike Stock Back in Focus as Cybersecurity Spending Holds Up, AI Debate Shifts

CrowdStrike shares closed Thursday up 1.75% at $392.62, still 31% below their 52-week high. The company launched Charlotte AI AgentWorks with partners including AWS and Anthropic at the RSA Conference on March 25. Fiscal 2026 revenue rose 22% to $4.81 billion, with annual recurring revenue at $5.25 billion. IBM expanded its partnership, integrating CrowdStrike’s AI into its threat-operations system.
27 March 2026
···
CrowdStrike Stock Gets Morgan Stanley Upgrade as Strong Outlook Blunts AI Fears

CrowdStrike Stock Gets Morgan Stanley Upgrade as Strong Outlook Blunts AI Fears

CrowdStrike shares held steady at $434.25 Tuesday after Morgan Stanley upgraded the stock and raised its price target to $510. The company forecast fiscal 2027 revenue above Wall Street estimates and reported fourth-quarter revenue up 23% to $1.31 billion. Costs tied to the July 2024 Windows outage rose to $117.7 million for fiscal 2026 but narrowed last quarter. CrowdStrike recently agreed to acquire SGNL and Seraphic Security.
10 March 2026
···
CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR

CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR

CrowdStrike shares traded near $391 Wednesday after volatile swings, following a fourth-quarter revenue jump of 23% to $1.31 billion and ARR of $5.25 billion, up 24%. The company’s fiscal 2027 revenue forecast topped Wall Street estimates. Investors are watching ARR growth and cash flow amid rising AI-driven competition. Costs tied to the 2024 Windows outage reached $117.7 million for fiscal 2026.
4 March 2026
···
CrowdStrike earnings lift CRWD stock after hours as ARR tops $5 billion and 2027 outlook holds

CrowdStrike earnings lift CRWD stock after hours as ARR tops $5 billion and 2027 outlook holds

CrowdStrike reported fourth-quarter revenue of $1.31 billion and adjusted profit of $1.12 per share, both above Wall Street estimates. Annual recurring revenue reached $5.25 billion. Shares rose about 2% in extended trading to $391.42. The company forecast fiscal 2027 revenue of up to $5.93 billion and ARR of up to $6.52 billion.
3 March 2026
····
CrowdStrike stock price slips into earnings week as CRWD rolls out FalconID, draws fresh target cut

CrowdStrike stock price slips into earnings week as CRWD rolls out FalconID, draws fresh target cut

CrowdStrike shares fell 2.39% to $371.98 on Friday, ending a two-day rally as tech stocks slid. Trading volume topped 5.1 million shares, above average. Jefferies cut its price target to $500, citing field checks, while the company launched FalconID, a new phishing-resistant MFA product. CrowdStrike reports quarterly results after the market closes on March 3.
28 February 2026
····
CrowdStrike stock drops as hot PPI and fresh target cuts put CRWD back in focus

CrowdStrike stock drops as hot PPI and fresh target cuts put CRWD back in focus

CrowdStrike shares fell 4% to $365.67 Friday after U.S. wholesale inflation rose 0.5% in January, pressuring software stocks. Analysts trimmed price targets but kept buy ratings ahead of CrowdStrike’s March 3 earnings, where consensus expects $0.74 per share. The company launched its FalconID authentication product Thursday. Peers like Zscaler also dropped after reporting losses.
27 February 2026
··
CrowdStrike stock steadies after Anthropic AI tool rattles cybersecurity names

CrowdStrike stock steadies after Anthropic AI tool rattles cybersecurity names

CrowdStrike shares closed down 0.02% at $350.25 Tuesday and slipped further in after-hours trading. The move followed a broader selloff in cybersecurity stocks sparked by concerns over new AI security tools from Anthropic. TD Cowen cut its price target on CrowdStrike to $480, citing market contraction. Investors await CrowdStrike’s March 3 earnings and outlook.
25 February 2026
···
MongoDB stock drops again after 11% rout as tariffs, AI jitters loom ahead of March 2 earnings

MongoDB stock drops again after 11% rout as tariffs, AI jitters loom ahead of March 2 earnings

MongoDB shares fell 3.8% to $293.81 by 9:31 a.m. ET Tuesday, extending Monday’s 11.4% drop amid a broader selloff in software stocks. Investors cited uncertainty over tariffs and fears that new artificial intelligence tools could threaten parts of the software sector. MongoDB will report quarterly results after markets close on March 2. The S&P 500 software and services index is down nearly 24% year-to-date.
24 February 2026
······
CrowdStrike stock sinks nearly 9% as AI disruption fears bite and Stifel trims target

CrowdStrike stock sinks nearly 9% as AI disruption fears bite and Stifel trims target

CrowdStrike shares dropped 8.8% to $354.25 in Monday morning trading, following renewed concerns that AI tools could pressure cybersecurity budgets and software pricing. Stifel cut its price target to $480 from $600. Broader tech stocks also fell after President Trump announced a new 15% global tariff. Investors await CrowdStrike’s earnings report on March 3 for further guidance.
23 February 2026
··
CrowdStrike stock steadies premarket after Anthropic’s Claude Code Security rattles cyber shares

CrowdStrike stock steadies premarket after Anthropic’s Claude Code Security rattles cyber shares

CrowdStrike shares rose 0.6% to $391 in premarket trading Monday after falling nearly 8% Friday, following Anthropic’s launch of an AI security tool that triggered a broader selloff in cybersecurity stocks. Investors are watching for CrowdStrike’s March 3 earnings and guidance, as concerns grow over AI-driven competition and market disruption.
23 February 2026
···
Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week

Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week

CrowdStrike shares fell 7.9% to $388.60 Friday after Anthropic launched a new Claude security feature, triggering a selloff in cybersecurity stocks. Cloudflare, Zscaler, SailPoint, and Okta also dropped, while the Global X Cybersecurity ETF closed at its lowest since November 2023. Anthropic’s tool scans code for vulnerabilities but is limited to select enterprise users. CrowdStrike reports earnings March 3.
21 February 2026
·
CrowdStrike stock price jumps on HSBC upgrade as CRWD heads into holiday-shortened week

CrowdStrike stock price jumps on HSBC upgrade as CRWD heads into holiday-shortened week

CrowdStrike shares jumped 4.4% to $429.64 Friday after HSBC upgraded the stock to “buy” with a $446 target, citing its cloud-native cybersecurity model. About 3.5 million shares changed hands as investors weighed AI’s impact on software firms. U.S. markets close Monday for Presidents Day. CrowdStrike will report quarterly results after the bell on March 3.
15 February 2026
··
AI stocks split on Wall Street: Nvidia rises as Microsoft slides on disruption fears

AI stocks split on Wall Street: Nvidia rises as Microsoft slides on disruption fears

Microsoft fell 2.6% and Palantir dropped 4.1% midday Wednesday, while Nvidia gained 1.5% and the semiconductor ETF SMH rose 2.2%. Alphabet slipped 2%. Investors shifted away from software-heavy AI stocks and into chipmakers ahead of U.S. inflation data and major tech earnings. Freshworks shares tumbled over 6% after a weak profit forecast.
11 February 2026
··········
ServiceNow stock rebounds after software rout as JPMorgan flags “AI-resilient” names

ServiceNow stock rebounds after software rout as JPMorgan flags “AI-resilient” names

ServiceNow shares rose 2.5% to $106.48 Tuesday, rebounding with other software stocks after a sharp selloff tied to AI disruption fears. JPMorgan and Morgan Stanley said recent declines were driven by sentiment, not fundamentals. UBS downgraded the U.S. tech sector to “Neutral,” citing ongoing risks. Traders are watching if the rally holds into Wednesday.
11 February 2026
·······
1 2 3 … 6

Stock Market Today

  • Bitmine Immersion Technologies Uplists to NYSE, Holds 5M+ ETH as Ethereum Proxy, Launches MAVAN Staking
    May 21, 2026, 12:11 AM EDT. Bitmine Immersion Technologies (NYSE:BMNR) has become a major Ethereum proxy by accumulating over 5 million ETH, representing more than 4.3% of Ethereum's total supply. The company uplisted to the NYSE and introduced MAVAN, an institutional-grade Ethereum staking platform, shifting its focus beyond mining to include staking services. BMNR stock closed at $19.39, trading below analyst targets and experiencing recent price declines despite longer-term gains. Investors should watch Ethereum price trends, staking yields, and institutional adoption of MAVAN, while noting BMNR remains loss-making and has diluted shareholders.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop